Cullen/Frost Bankers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.91M | Hold |
3,554
| – | – | 0.02% | 263 |
|
2025
Q1 | $1.49M | Sell |
3,554
-63
| -2% | -$26.5K | 0.02% | 271 |
|
2024
Q4 | $1.5M | Buy |
3,617
+52
| +1% | +$21.5K | 0.02% | 267 |
|
2024
Q3 | $1.8M | Buy |
3,565
+7
| +0.2% | +$3.54K | 0.02% | 249 |
|
2024
Q2 | $1.73M | Buy |
3,558
+8
| +0.2% | +$3.9K | 0.03% | 250 |
|
2024
Q1 | $1.92M | Hold |
3,550
| – | – | 0.03% | 249 |
|
2023
Q4 | $1.97M | Sell |
3,550
-88
| -2% | -$48.8K | 0.03% | 243 |
|
2023
Q3 | $1.59M | Sell |
3,638
-31
| -0.8% | -$13.6K | 0.03% | 266 |
|
2023
Q2 | $1.84M | Buy |
3,669
+3,541
| +2,766% | +$1.78M | 0.03% | 257 |
|
2023
Q1 | $64K | Sell |
128
-67
| -34% | -$33.5K | ﹤0.01% | 681 |
|
2022
Q4 | $79.6K | Sell |
195
-1,164
| -86% | -$475K | ﹤0.01% | 637 |
|
2022
Q3 | $443K | Hold |
1,359
| – | – | 0.01% | 393 |
|
2022
Q2 | $477K | Buy |
1,359
+1,154
| +563% | +$405K | 0.01% | 382 |
|
2022
Q1 | $112K | Buy |
205
+3
| +1% | +$1.64K | ﹤0.01% | 613 |
|
2021
Q4 | $133K | Sell |
202
-49
| -20% | -$32.3K | ﹤0.01% | 590 |
|
2021
Q3 | $156K | Hold |
251
| – | – | ﹤0.01% | 563 |
|
2021
Q2 | $159K | Buy |
251
+44
| +21% | +$27.9K | ﹤0.01% | 567 |
|
2021
Q1 | $101K | Sell |
207
-72
| -26% | -$35.1K | ﹤0.01% | 609 |
|
2020
Q4 | $139K | Buy |
279
+100
| +56% | +$49.8K | ﹤0.01% | 538 |
|
2020
Q3 | $70K | Buy |
179
+70
| +64% | +$27.4K | ﹤0.01% | 607 |
|
2020
Q2 | $36K | Buy |
+109
| New | +$36K | ﹤0.01% | 717 |
|
2020
Q1 | – | Sell |
-3
| Closed | -$1K | – | 960 |
|
2019
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1016 |
|